GSK Gsk Plc

TIDMGSK

RNS Number : 7375Z

GlaxoSmithKline PLC

16 March 2017

GlaxoSmithKline plc (the 'Company')

Transaction notification

 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ======================================================================= 
 a)   Name                     Dr M M Slaoui 
===  ========================  ============================================= 
 b)   Position/status          Chairman, Global Vaccines 
===  ========================  ============================================= 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ======================================================================= 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================= 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ======================================================================= 
 a)   Description of           GlaxoSmithKline plc American Depositary 
       the financial            Shares ('ADSs') 
       instrument               ISIN: US37733W1053 
===  ========================  ============================================= 
 b)   Nature of the             An increase of 4 ADSs following the notional 
       transaction               allocation of ADSs on 15 March 2017, at 
                                 a price of $42.00 per ADS, as a result 
                                 of the revaluation of the cash element 
                                 of the notional investment held within 
                                 the GSK 401(K) plan. 
===  ========================  ============================================= 
 c)   Price(s) and               Price(s)   Volume(s) 
       volume(s)                 ---------  ---------- 
                                  $42.00     4 
                                 ---------  ---------- 
===  ========================  ============================================= 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  ============================================= 
 e)   Date of the transaction  2017-03-15 
===  ========================  ============================================= 
 f)   Place of the              n/a 
       transaction 
===  ========================  ============================================= 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ======================================================================= 
 a)   Name                     Dr K Slaoui 
===  ========================  ============================================= 
 b)   Position/status          PCA of Dr M M Slaoui (Chairman, Global 
                                Vaccines) 
===  ========================  ============================================= 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ======================================================================= 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================= 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ======================================================================= 
 a)   Description of            GlaxoSmithKline plc American Depositary 
       the financial             Shares ('ADSs') 
       instrument                ISIN: US37733W1053 
===  ========================  ============================================= 
 b)   Nature of the            An increase of 91 ADSs following the notional 
       transaction              allocation of ADSs on 15 March 2017, at 
                                a price of $42.00 per ADS, as a result 
                                of the revaluation of the cash element 
                                of the notional investment held within 
                                the GSK 401(K) plan. 
===  ========================  ============================================= 
 c)   Price(s) and               Price(s)   Volume(s) 
       volume(s)                 ---------  ---------- 
                                  $42.00     91 
                                 ---------  ---------- 
===  ========================  ============================================= 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  ============================================= 
 e)   Date of the transaction  2017-03-15 
===  ========================  ============================================= 
 f)   Place of the              n/a 
       transaction 
===  ========================  ============================================= 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHQQLFFDXFFBBF

(END) Dow Jones Newswires

March 16, 2017 12:13 ET (16:13 GMT)

Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024

Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024